SpineGuard has signed an agreement with MBA, a medical device marketer and distributor that specializes in the sale of products used for the treatment of spine, to exclusively distribute PediGuard device in Italy, Portugal, Spain and the UK, effective immediately.
SpineGuard said that PediGuard, which is CE-Marked and FDA-cleared, is designed for safer pedicle screw placement in spine surgery.
Pierre Jerome, CEO of SpineGuard, said: “I have been particularly impressed by the quality of MBA’s management team and by their state-of-the-art training facilities. I look forward to a fruitful collaboration between SpineGuard and MBA and seeing PediGuard become a standard of care for pedicle screw placement in the UK, Spain, Portugal and Italy.”
Paul Griffin, chief operating officer and a member of the board of directors at MBA, said: “This exciting and highly innovative technology has the potential to significantly reduce serious complications in patients undergoing major spine surgery. Our exclusive agreement opens the way for MBA to immediately begin introduction of this very useful product to specialists throughout the UK, Spain, Italy and Portugal.
“SpineGuard has state-of-the-art technology and MBA has the resources to bring this exceptional product quickly and successfully into regular use in some of the principal and most competitive markets outside the US.”